Developer docs
API playgroundTry for free, no card

Search company profiles

Society For Experimental Biology & Medicine

Full company profile

uuid003lj36

Namestring
Society For Experimental Biology & Medicine
Legal namestring
Society for Experimental Biology and Medicine
Websiteurl
sebm.org
Company typeenum
Private
Founded yearint
1903
Descriptiontext

Society for Experimental Biology and Medicine (SEBM) is a 501(c)(3) nonprofit scientific society founded in 1903 and headquartered in Washington, D.C. The society's mission is to promote investigation in the biomedical sciences and foster the career development of students, physician-scientists, and new investigators. SEBM serves approximately 1,000 members worldwide, the majority of whom hold doctoral degrees and are actively engaged in biomedical research across academic and clinical institutions.

SEBM's core product is its peer-reviewed flagship journal, Experimental Biology and Medicine (EBM), an open-access publication covering the intersection of biology, medicine, engineering, and the physical sciences. The journal was previously published as Proceedings of the Society for Experimental Biology and Medicine (PSEBM) from 1903 through 2000. Complementary offerings include the SEBM Annual Meeting (held jointly with the Society of Toxicology), the International Experimental Biology and Medicine Conference, an on-demand webinar series, a member directory, and an awards program encompassing Young Investigator Awards ($500 travel grants), Distinguished Scientist Awards, and Best Paper Awards (Peter Stambrook, Burton E. Sobel, and Alan MacDiarmid categories). The society's technology infrastructure is built on Wild Apricomembership management software for enrollment, renewals, and member communications.

SEBM generates revenue through three primary streams: tiered annual membership dues ($60 for postdoctoral, $120 for regular, variable for students, $150 for sustaining members), article processing charges for open-access journal publication (with member discounts), and tax-deductible donations supporting educational conferences and student scholarships. The society is member-supported and governed by an elected Council including a President, President-Elect, Immediate Past President, Treasurer, and twelve Councilors, with operating geographies spanning the United States and international members from institutions in Brazil, Australia, and elsewhere.

Short descriptiontext

Society for Experimental Biology and Medicine is a 501(c)(3) nonprofit scientific society, founded in 1903, that publishes the peer-reviewed journal Experimental Biology and Medicine and serves approximately 1,000 doctoral-level biomedical researchers worldwide through membership, conferences, webinars, and awards.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical scientific society, peer-reviewed journal publishing, scientific conference services, research membership organization, academic career development
NAICS code2 codes
  • Management, Scientific, and Technical Consulting Services5416
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Engineering, Accounting, Research, Management8700
Product category
Scientific Publishing & Professional Society Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Membership Dues
TypeSubscription Recurring
Description

SEBM generates revenue through annual membership dues at varying levels: Post Doctoral Member ($60/year), Regular Member ($120/year), Student Member (variable pricing), and Sustaining Member ($150/year). Membership provides access to the journal at member rates, discounts on conference registration, and voting privileges.

sebm.org
2Journal Publication Charges
TypeLicensing Royalties
Description

Authors may be charged article processing charges for publication in Experimental Biology and Medicine, the society's flagship open-access journal. Members receive discounts on these article processing charges.

sebm.org
3Donations and Contributions
TypeAffiliate Referral
Description

SEBM accepts donations to support educational conferences and scholarships for students. The society is a registered 501(c)(3) nonprofit organization (EIN: 13-1635283).

sebm.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details4 tiers
1Post Doctoral Member - $60.00/year
ModelSubscriptionBilling cadenceAnnual
Notes

Available to any postdoctoral trainee. Subscription period: 1 year with automatic renewal.

sebm.org
2Regular Member - $120.00/year
ModelSubscriptionBilling cadenceAnnual
Notes

Requires doctoral level degree and evidence of independent research and publication. Includes voting rights, office holding, and committee membership privileges.

sebm.org
3Student Member - Variable pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Available to undergraduate or graduate students in research areas related to experimental biology or medicine, endorsed by research advisor. Membership lasts until degree completion or full-time employment.

sebm.org
4Sustaining Member - $150.00/year
ModelSubscriptionBilling cadenceAnnual
Notes

For actively involved researchers in experimental biology or biomedical research.

sebm.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Experimental Biology and Medicine (EBM)
Description

Official flagship open-access journal of SEBM publishing peer-reviewed research at the intersection of biology, medicine, engineering, and the physical sciences.

sebm.org
Core offering1 text field

SEBM is a nonprofit scientific society that publishes the peer-reviewed open-access journal Experimental Biology and Medicine (EBM), hosts an annual multidisciplinary scientific conference, and runs a tiered membership program (Post Doctoral, Regular, Student, Sustaining) with benefits including discounted journal access, conference registration discounts, webinars, and awards/scholarships. Its products and services are targeted at biomedical researchers, students, postdoctoral trainees, physician-scientists, and new investigators worldwide.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SEBM operates as a non-profit scientific society offering a unified portfolio of member services centered on its flagship peer-reviewed journal, Experimental Biology and Medicine (EBM), alongside complementary programs. The core product is EBM, supported by membership subscriptions, webinars, annual conferences, and awards programs. These offerings work together to advance investigation in biomedical sciences and foster career development of students, physician-scientists, and new investigators.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMajorTypeStrategic or Co-development Partner
Description

SEBM hosts its Annual Meeting in conjunction with the Society of Toxicology. This partnership enables joint scientific programming focused on topics such as new approach methodologies (NAMs) to understand human health and disease across diverse populations.

Strategic tierCoreTypeTechnology or Integration
Description

Wild Apricot provides membership management software powering the SEBM website, including membership database, event registration, email communications, and member directory functionality.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Society For Experimental Biology & Medicine

Scientific Publishing & Professional Society Servicessebm.org

Society for Experimental Biology and Medicine is a 501(c)(3) nonprofit scientific society, founded in 1903, that publishes the peer-reviewed journal Experimental Biology and Medicine and serves approximately 1,000 doctoral-level biomedical researchers worldwide through membership, conferences, webinars, and awards.

What Society For Experimental Biology & Medicine does

Society for Experimental Biology and Medicine (SEBM) is a 501(c)(3) nonprofit scientific society founded in 1903 and headquartered in Washington, D.C. The society's mission is to promote investigation in the biomedical sciences and foster the career development of students, physician-scientists, and new investigators. SEBM serves approximately 1,000 members worldwide, the majority of whom hold doctoral degrees and are actively engaged in biomedical research across academic and clinical institutions.

SEBM's core product is its peer-reviewed flagship journal, Experimental Biology and Medicine (EBM), an open-access publication covering the intersection of biology, medicine, engineering, and the physical sciences. The journal was previously published as Proceedings of the Society for Experimental Biology and Medicine (PSEBM) from 1903 through 2000. Complementary offerings include the SEBM Annual Meeting (held jointly with the Society of Toxicology), the International Experimental Biology and Medicine Conference, an on-demand webinar series, a member directory, and an awards program encompassing Young Investigator Awards ($500 travel grants), Distinguished Scientist Awards, and Best Paper Awards (Peter Stambrook, Burton E. Sobel, and Alan MacDiarmid categories). The society's technology infrastructure is built on Wild Apricomembership management software for enrollment, renewals, and member communications.

SEBM generates revenue through three primary streams: tiered annual membership dues ($60 for postdoctoral, $120 for regular, variable for students, $150 for sustaining members), article processing charges for open-access journal publication (with member discounts), and tax-deductible donations supporting educational conferences and student scholarships. The society is member-supported and governed by an elected Council including a President, President-Elect, Immediate Past President, Treasurer, and twelve Councilors, with operating geographies spanning the United States and international members from institutions in Brazil, Australia, and elsewhere.

Society For Experimental Biology & Medicine firmographics

Firmographics
Name
Society For Experimental Biology & Medicine
Legal name
Society for Experimental Biology and Medicine
Website
https://sebm.org
Company type
Private
Founded year
1903
Operating status
Operating
Headcount range
1–10 employees
Short description
Society for Experimental Biology and Medicine is a 501(c)(3) nonprofit scientific society, founded in 1903, that publishes the peer-reviewed journal Experimental Biology and Medicine and serves approximately 1,000 doctoral-level biomedical researchers worldwide through membership, conferences, webinars, and awards.
Ownership category
akta.pro rank

Where Society For Experimental Biology & Medicine is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Society For Experimental Biology & Medicine business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Membership Dues: SEBM generates revenue through annual membership dues at varying levels: Post Doctoral Member ($60/year), Regular Member ($120/year), Student Member (variable pricing), and Sustaining Member ($150/year). Membership provides access to the journal at member rates, discounts on conference registration, and voting privileges.
  2. Journal Publication Charges: Authors may be charged article processing charges for publication in Experimental Biology and Medicine, the society's flagship open-access journal. Members receive discounts on these article processing charges.
  3. Donations and Contributions: SEBM accepts donations to support educational conferences and scholarships for students. The society is a registered 501(c)(3) nonprofit organization (EIN: 13-1635283).

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPost Doctoral Member - $60.00/year
SubscriptionAnnualRegular Member - $120.00/year
SubscriptionAnnualStudent Member - Variable pricing
SubscriptionAnnualSustaining Member - $150.00/year

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Society For Experimental Biology & Medicine product offering

Product offering

Core offering

SEBM is a nonprofit scientific society that publishes the peer-reviewed open-access journal Experimental Biology and Medicine (EBM), hosts an annual multidisciplinary scientific conference, and runs a tiered membership program (Post Doctoral, Regular, Student, Sustaining) with benefits including discounted journal access, conference registration discounts, webinars, and awards/scholarships. Its products and services are targeted at biomedical researchers, students, postdoctoral trainees, physician-scientists, and new investigators worldwide.

Product overview

SEBM operates as a non-profit scientific society offering a unified portfolio of member services centered on its flagship peer-reviewed journal, Experimental Biology and Medicine (EBM), alongside complementary programs. The core product is EBM, supported by membership subscriptions, webinars, annual conferences, and awards programs. These offerings work together to advance investigation in biomedical sciences and foster career development of students, physician-scientists, and new investigators.

Differentiator

Problem solved

Functional benefit

Brands

  • Experimental Biology and Medicine (EBM): Official flagship open-access journal of SEBM publishing peer-reviewed research at the intersection of biology, medicine, engineering, and the physical sciences.

Companies that use Society For Experimental Biology & Medicine

Customer profile

Segments4 records

Ideal customer profiles2 records

Society For Experimental Biology & Medicine technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Society For Experimental Biology & Medicine partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered major and core.

  • Society of ToxicologymajorStrategic or Co-development PartnerSEBM hosts its Annual Meeting in conjunction with the Society of Toxicology. This partnership enables joint scientific programming focused on topics such as new approach methodologies (NAMs) to understand human health and disease across diverse populations.
  • Wild ApricotcoreTechnology or IntegrationWild Apricot provides membership management software powering the SEBM website, including membership database, event registration, email communications, and member directory functionality.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Society For Experimental Biology & Medicine competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Society For Experimental Biology & Medicine social profiles

Digital presence

Society For Experimental Biology & Medicine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Society For Experimental Biology & Medicine leadership team

Management profile

Number of profiles

Society For Experimental Biology & Medicine funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Society For Experimental Biology & Medicine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Society For Experimental Biology & Medicine

What does Society For Experimental Biology & Medicine do?

SEBM is a nonprofit scientific society that publishes the peer-reviewed open-access journal Experimental Biology and Medicine (EBM), hosts an annual multidisciplinary scientific conference, and runs a tiered membership program (Post Doctoral, Regular, Student, Sustaining) with benefits including discounted journal access, conference registration discounts, webinars, and awards/scholarships. Its products and services are targeted at biomedical researchers, students, postdoctoral trainees, physician-scientists, and new investigators worldwide.

Is Society For Experimental Biology & Medicine a public or private company?

Society For Experimental Biology & Medicine is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Society For Experimental Biology & Medicine founded?

Society For Experimental Biology & Medicine was founded in 1903. It employs 1 to 10 people.

Where is Society For Experimental Biology & Medicine based?

Society For Experimental Biology & Medicine is headquartered in Washington, United States, in the North America region.

How does Society For Experimental Biology & Medicine make money?

Three revenue lines are on record. Membership Dues are the primary driver. The others are journal Publication Charges and donations and Contributions.

Does Society For Experimental Biology & Medicine have an API?

No public API is recorded for Society For Experimental Biology & Medicine.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FrontiersFrontiers welcomes new publishing partnership with the Society for Experimental Biology and MedicineFrontiers has signed an agreement with the Society for Experimental Biology and Medicine to take over publishing the journal Experimental Biology and Medicine (EBM) from SAGE. The transition, finalized in October 2022, will move EBM to a fully open access model on Frontiers' platform by late 2023, with the first papers expected in early 2024. This partnership expands Frontiers' community of society partners in North America and aims to better support the global research community through open access.GlobeNewswirePain Intensity in Sickle Cell DiseaseA study led by Dr. Keesha Powell-Roach found that COMT and DRD3 haplotypes are associated with pain intensity and acute care utilization in sickle cell disease. The findings suggest genetic contributions to pain phenotypes, which could improve medical management. The study was published in Experimental Biology and Medicine.GlobeNewswirePotential Risk for Methadone Treatment in PregnancyA study published in Experimental Biology and Medicine found that antenatal methadone exposure impairs oligodendrocyte development and myelination in neonatal rat brains. The findings suggest decreased nerve conduction and white matter development, raising concerns for fetal brain outcomes. The authors call for further research and alternative treatments.GlobeNewswireThe Impact of Emerging Technologies on Regulatory ScienceA published article in Experimental Biology and Medicine highlights the need for emerging technologies in regulatory science, coordinated by Dr. William Slikker, Jr. of the FDA. It calls for collaboration among regulators, industry, and academia to verify novel safety assessment tools. The article urges work together to develop strategies for evaluating these new approaches.GlobeNewswireThree New Articles Focus on COVID-19: Diagnosis and Risk FactorsExperimental Biology and Medicine published three COVID-19 articles: osteopontin as a biomarker for severity in children, a rapid colorimetric RT-LAMP test, and waist circumference as a mortality risk indicator. The waist-circumference study of 367 patients found abdominal obesity, not diabetes, linked to higher death risk.PR NewswireNew Therapeutic Target for Sickle Cell DiseaseA study led by researchers at Augusta University published in Experimental Biology and Medicine identifies NRF2 as a key transcription factor regulating fetal hemoglobin expression, offering a potential new therapeutic target for sickle cell disease. The research utilized a novel knockout mouse model to demonstrate that manipulating NRF2 can influence globin gene expression, addressing the limitations of current treatments like hydroxyurea.PR NewswireA New Class of Kinase Inhibitors for the Treatment of Cardiovascular DiseaseA study led by Dr. Robert Schwartz at the University of Houston and The Texas Heart Institute identified a new class of peptide kinase inhibitors that facilitate vascular relaxation by targeting specific sites on Rho-activated kinases (ROCKs). This research, published in Experimental Biology and Medicine, offers a strategy to overcome the side effects associated with current small-molecule therapeutics for hypertension and cardiovascular disease.